Full Text View
Tabular View
No Study Results Posted
Related Studies
Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
This study is currently recruiting participants.
Study NCT00197418   Information provided by Hamamatsu University
First Received: September 12, 2005   Last Updated: March 20, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Helicobacter Infections
Gastritis
Gastric Ulcer
Duodenal Ulcer
Additional conditions recognized in this trial
Communicable Diseases
Infection
Stomach Ulcer
Ulcer
More general conditions related to this trial
Bacterial Infections
Digestive System Diseases
Duodenal Diseases
Gastroenteritis
Gastrointestinal Diseases
Gram-Negative Bacterial Infections
Intestinal Diseases
Pathologic Processes
Peptic Ulcer
Stomach Diseases
Additional drug interventions recognized in this trial
Amoxicillin
Clarithromycin
Metronidazole
Rabeprazole
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Ulcer Agents
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Synthesis Inhibitors
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Hamamatsu University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services